ATR-01 — IND submission
2026
We are planning to perform lead optimization and IND-enabling studies in 2025 to support an IND filing in 2026.Source filing
AZTR biotech catalysts & pipeline
AZITRA INC · Data as of 2026-10-27
Upcoming catalysts
ATR-12 — Topline data
H2 2026
• Topline data from the Phase 1b trial is anticipated H2 2026.Source filing
ATR-COSF — Initial data
by year end
A first-in-human clinical study of 4% ATR-COSF is anticipated in approximately 30 subjects with initial data expected by year end.Source filing
ATR-04 — Topline data
Q4-2026
Topline data from first cohort of Phase 1/2 trial expected in Q4-2026.Source filing
ATR-COSF — Conference presentation
Nov 10
The detailed data will be presented in person at the BIO-Europe ® conference in Cologne, Germany on November 10 th , 2026, at 4:45 pm CET.Source filing